Table 2.
Patterns of Care by Sex
| Characteristic | Overall (n = 7362) | Female (n = 5417) | Male (n = 1945) | P value |
|---|---|---|---|---|
| No. (column %) | ||||
| Source of care | ||||
| Co-managed* | 1828 (25) | 1366 (25) | 462 (24) | < .001 |
| PCP only† | 1288 (17) | 1021 (19) | 267 (14) | |
| Urologist only‡ | 938 (13) | 374 (7) | 564 (29) | |
| Gynecologist only§ | 195 (3) | 195 (4) | 0 (0) | |
| Urogynecologist only║ | 76 (1) | 76 (1) | 0 (0) | |
| Urologist, gynecologist, and/or urogynecologist only¶ | 637 (9) | 633 (12) | 4 (0) | |
| Other# | 2400 (33) | 1752 (32) | 648 (33) | |
| Total | 7362 (100) | 5417 (100) | 1945 (100) | |
| Initial medication | ||||
| Darifenacin | 100 (1) | 75 (1) | 25 (1) | .006 |
| Fesoterodine | 55 (1) | 41 (1) | 14 (1) | |
| Flavoxate | 9 (0) | 9 (0) | 0 (0) | |
| Hyoscyamine | 83 (1) | 65 (1) | 18 (1) | |
| Imipramine | 133 (2) | 103 (2) | 30 (2) | |
| Mirabegron | 27 (0) | 20 (0) | 7 (0) | |
| Oxybutynin | 1545 (21) | 1184 (22) | 361 (19) | |
| Solifenacin | 428 (6) | 324 (6) | 104 (5) | |
| Tolterodine | 485 (7) | 359 (7) | 126 (6) | |
| Trospium | 91 (1) | 75 (1) | 16 (1) | |
| None | 4406 (60) | 3162 (58) | 1244 (64) | |
| Total | 7362 (100) | 5417 (100) | 1945 (100) | |
| Treatment | ||||
| Biofeedback | 10 (0) | 9 (0) | 1 (0) | .24 |
| No biofeedback | 7352 (100) | 5408 (100) | 1944 (100) | |
| Total | 7362 (100) | 5417 (100) | 1945 (100) | |
| OnabotulinumtoxinA | 171 (2) | 131 (2) | 40 (2) | .36 |
| No onabotulinumtoxinA | 7191 (98) | 5286 (98) | 1905 (98) | |
| Total | 7362 (100) | 5417 (100) | 1945 (100) | |
| Sacral nerve stimulation | 74 (1) | 56 (1) | 18 (1) | .68 |
| No sacral nerve stimulation | 7288 (99) | 5361 (99) | 1927 (99) | |
| Total | 7362 (100) | 5417 (100) | 1945 (100) | |
| Bladder augmentation | 0 (0) | 0 (0) | 0 (0) | NA |
| No bladder augmentation | 7362 (100) | 5417 (100) | 1945 (100) | |
| Total | 7362 (100) | 5417 (100) | 1945 (100) | |
NA, not applicable; PCP, primary care physician.
*Patients with a PCP who also received care from a urologist, gynecologist, and/or urogynecologist
†Patients with a PCP who did not receive care from a urologist, gynecologist, or urogynecologist
‡Patients with a urologist who did not receive care from a PCP, gynecologist, or urogynecologist
§Patients with a gynecologist who did not receive care from a PCP, urologist, or urogynecologist
║Patients with a urogynecologist who did not receive care from a PCP, gynecologist, or urologist
¶Patients with a urologist, gynecologist, and/or urogynecologist (at least two of three) who did not receive care from a PCP
#Patients who did not receive care from a PCP, urologist, gynecologist, or urogynecologist but received care from other specialists